Tower Research Capital LLC (Trc) Xeris Biopharma Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,671 shares of XERS stock, worth $12,481. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,671
Previous 25,594
85.66%
Holding current value
$12,481
Previous $57,000
82.46%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XERS
# of Institutions
143Shares Held
60MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$35.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.4 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.4 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$11.8 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.3 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $462M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...